NDA Submission of Paltusotine for Acromegaly
13:53
FDA Approval of Setmelanotide for Patients 2 Years and Older With MC4R Pathway Diseases
36:53
Personalized therapy in Acromegaly by Dr. Shlomo Melmed
10:26
Bird Flu Update Explained by a Veterinary Professional
49:16
Pituitary Disorders | Clinical Medicine
1:12:11
Crinetics Topline Results from Paltusotine Phase 3 PATHFNDR 1 Study
23:28
Quesmed MRCP PACES Consultation Station: Acromegaly
21:02
Pituitary tumors: Mayo Clinic Radio
8:29